Logo image of ACHC

ACADIA HEALTHCARE CO INC (ACHC) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ACHC - US00404A1097 - Common Stock

14.46 USD
+0.05 (+0.35%)
Last: 12/22/2025, 8:25:56 PM
14.46 USD
0 (0%)
After Hours: 12/22/2025, 8:25:56 PM
Fundamental Rating

4

Taking everything into account, ACHC scores 4 out of 10 in our fundamental rating. ACHC was compared to 102 industry peers in the Health Care Providers & Services industry. ACHC has a medium profitability rating, but doesn't score so well on its financial health evaluation. ACHC has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ACHC was profitable.
In the past year ACHC had a positive cash flow from operations.
In multiple years ACHC reported negative net income over the last 5 years.
Each year in the past 5 years ACHC had a positive operating cash flow.
ACHC Yearly Net Income VS EBIT VS OCF VS FCFACHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

ACHC has a Return On Assets (1.67%) which is comparable to the rest of the industry.
ACHC has a Return On Equity (3.44%) which is comparable to the rest of the industry.
ACHC has a Return On Invested Capital (5.82%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for ACHC is in line with the industry average of 9.61%.
Industry RankSector Rank
ROA 1.67%
ROE 3.44%
ROIC 5.82%
ROA(3y)3.12%
ROA(5y)0.6%
ROE(3y)5.75%
ROE(5y)-2.11%
ROIC(3y)7.93%
ROIC(5y)7.15%
ACHC Yearly ROA, ROE, ROICACHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

ACHC's Profit Margin of 3.29% is fine compared to the rest of the industry. ACHC outperforms 69.61% of its industry peers.
ACHC's Profit Margin has improved in the last couple of years.
ACHC's Operating Margin of 13.59% is amongst the best of the industry. ACHC outperforms 83.33% of its industry peers.
In the last couple of years the Operating Margin of ACHC has remained more or less at the same level.
Industry RankSector Rank
OM 13.59%
PM (TTM) 3.29%
GM N/A
OM growth 3Y-1.13%
OM growth 5Y1.15%
PM growth 3Y-0.53%
PM growth 5Y8.37%
GM growth 3YN/A
GM growth 5YN/A
ACHC Yearly Profit, Operating, Gross MarginsACHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACHC is destroying value.
Compared to 1 year ago, ACHC has more shares outstanding
ACHC has more shares outstanding than it did 5 years ago.
ACHC has a worse debt/assets ratio than last year.
ACHC Yearly Shares OutstandingACHC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ACHC Yearly Total Debt VS Total AssetsACHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.11, we must say that ACHC is in the distress zone and has some risk of bankruptcy.
ACHC has a Altman-Z score of 1.11. This is in the lower half of the industry: ACHC underperforms 71.57% of its industry peers.
A Debt/Equity ratio of 0.73 indicates that ACHC is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.73, ACHC perfoms like the industry average, outperforming 49.02% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF N/A
Altman-Z 1.11
ROIC/WACC0.65
WACC8.9%
ACHC Yearly LT Debt VS Equity VS FCFACHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.44 indicates that ACHC should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.44, ACHC is in line with its industry, outperforming 53.92% of the companies in the same industry.
A Quick Ratio of 1.43 indicates that ACHC should not have too much problems paying its short term obligations.
ACHC's Quick ratio of 1.43 is in line compared to the rest of the industry. ACHC outperforms 59.80% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.43
ACHC Yearly Current Assets VS Current LiabilitesACHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

3

3. Growth

3.1 Past

ACHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.21%.
ACHC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.21% yearly.
The Revenue has been growing slightly by 4.58% in the past year.
Measured over the past years, ACHC shows a quite strong growth in Revenue. The Revenue has been growing by 9.45% on average per year.
EPS 1Y (TTM)-26.21%
EPS 3Y8.69%
EPS 5Y10.21%
EPS Q2Q%-20.88%
Revenue 1Y (TTM)4.58%
Revenue growth 3Y10.87%
Revenue growth 5Y9.45%
Sales Q2Q%4.41%

3.2 Future

The Earnings Per Share is expected to decrease by -8.28% on average over the next years.
The Revenue is expected to grow by 6.03% on average over the next years.
EPS Next Y-27.2%
EPS Next 2Y-17.22%
EPS Next 3Y-9.71%
EPS Next 5Y-8.28%
Revenue Next Year4.25%
Revenue Next 2Y4.31%
Revenue Next 3Y4.65%
Revenue Next 5Y6.03%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACHC Yearly Revenue VS EstimatesACHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
ACHC Yearly EPS VS EstimatesACHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 5.58 indicates a rather cheap valuation of ACHC.
Based on the Price/Earnings ratio, ACHC is valued cheaply inside the industry as 97.06% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.61. ACHC is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 6.39, the valuation of ACHC can be described as very cheap.
98.04% of the companies in the same industry are more expensive than ACHC, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 24.01. ACHC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 5.58
Fwd PE 6.39
ACHC Price Earnings VS Forward Price EarningsACHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ACHC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ACHC is cheaper than 92.16% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.62
ACHC Per share dataACHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

ACHC's earnings are expected to decrease with -9.71% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.55
EPS Next 2Y-17.22%
EPS Next 3Y-9.71%

0

5. Dividend

5.1 Amount

ACHC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ACADIA HEALTHCARE CO INC

NASDAQ:ACHC (12/22/2025, 8:25:56 PM)

After market: 14.46 0 (0%)

14.46

+0.05 (+0.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-25 2026-02-25/amc
Inst Owners127.11%
Inst Owner Change9.11%
Ins Owners1.25%
Ins Owner Change0.86%
Market Cap1.33B
Revenue(TTM)3.27B
Net Income(TTM)107.36M
Analysts79
Price Target22 (52.14%)
Short Float %15.99%
Short Ratio5.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.19%
Min EPS beat(2)5.25%
Max EPS beat(2)17.12%
EPS beat(4)3
Avg EPS beat(4)5.03%
Min EPS beat(4)-12.21%
Max EPS beat(4)17.12%
EPS beat(8)6
Avg EPS beat(8)3.57%
EPS beat(12)9
Avg EPS beat(12)2.45%
EPS beat(16)12
Avg EPS beat(16)8.69%
Revenue beat(2)1
Avg Revenue beat(2)0.08%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)1.45%
Revenue beat(4)1
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)1.45%
Revenue beat(8)2
Avg Revenue beat(8)-1.31%
Revenue beat(12)5
Avg Revenue beat(12)-0.68%
Revenue beat(16)5
Avg Revenue beat(16)-0.75%
PT rev (1m)-26.34%
PT rev (3m)-28.77%
EPS NQ rev (1m)-43.76%
EPS NQ rev (3m)-58.7%
EPS NY rev (1m)-4.89%
EPS NY rev (3m)-7.56%
Revenue NQ rev (1m)-0.46%
Revenue NQ rev (3m)-3.93%
Revenue NY rev (1m)-0.65%
Revenue NY rev (3m)-0.89%
Valuation
Industry RankSector Rank
PE 5.58
Fwd PE 6.39
P/S 0.41
P/FCF N/A
P/OCF 3.98
P/B 0.43
P/tB 1.78
EV/EBITDA 5.62
EPS(TTM)2.59
EY17.91%
EPS(NY)2.26
Fwd EY15.64%
FCF(TTM)-3.76
FCFYN/A
OCF(TTM)3.63
OCFY25.1%
SpS35.4
BVpS33.82
TBVpS8.11
PEG (NY)N/A
PEG (5Y)0.55
Graham Number44.39
Profitability
Industry RankSector Rank
ROA 1.67%
ROE 3.44%
ROCE 7.53%
ROIC 5.82%
ROICexc 5.94%
ROICexgc 10.08%
OM 13.59%
PM (TTM) 3.29%
GM N/A
FCFM N/A
ROA(3y)3.12%
ROA(5y)0.6%
ROE(3y)5.75%
ROE(5y)-2.11%
ROIC(3y)7.93%
ROIC(5y)7.15%
ROICexc(3y)8.08%
ROICexc(5y)7.37%
ROICexgc(3y)16.06%
ROICexgc(5y)14.72%
ROCE(3y)10.25%
ROCE(5y)9.25%
ROICexgc growth 3Y-4.56%
ROICexgc growth 5Y16.02%
ROICexc growth 3Y1.65%
ROICexc growth 5Y14.56%
OM growth 3Y-1.13%
OM growth 5Y1.15%
PM growth 3Y-0.53%
PM growth 5Y8.37%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF N/A
Debt/EBITDA 3.65
Cap/Depr 372.67%
Cap/Sales 20.89%
Interest Coverage 250
Cash Conversion 53.43%
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 1.43
Altman-Z 1.11
F-Score4
WACC8.9%
ROIC/WACC0.65
Cap/Depr(3y)344.44%
Cap/Depr(5y)299.77%
Cap/Sales(3y)15.9%
Cap/Sales(5y)13.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.21%
EPS 3Y8.69%
EPS 5Y10.21%
EPS Q2Q%-20.88%
EPS Next Y-27.2%
EPS Next 2Y-17.22%
EPS Next 3Y-9.71%
EPS Next 5Y-8.28%
Revenue 1Y (TTM)4.58%
Revenue growth 3Y10.87%
Revenue growth 5Y9.45%
Sales Q2Q%4.41%
Revenue Next Year4.25%
Revenue Next 2Y4.31%
Revenue Next 3Y4.65%
Revenue Next 5Y6.03%
EBIT growth 1Y-18.4%
EBIT growth 3Y9.61%
EBIT growth 5Y10.7%
EBIT Next Year12.85%
EBIT Next 3Y6.91%
EBIT Next 5Y11.46%
FCF growth 1Y-499.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.13%
OCF growth 3Y-29.78%
OCF growth 5Y-15.9%

ACADIA HEALTHCARE CO INC / ACHC FAQ

What is the fundamental rating for ACHC stock?

ChartMill assigns a fundamental rating of 4 / 10 to ACHC.


Can you provide the valuation status for ACADIA HEALTHCARE CO INC?

ChartMill assigns a valuation rating of 6 / 10 to ACADIA HEALTHCARE CO INC (ACHC). This can be considered as Fairly Valued.


Can you provide the profitability details for ACADIA HEALTHCARE CO INC?

ACADIA HEALTHCARE CO INC (ACHC) has a profitability rating of 5 / 10.


How financially healthy is ACADIA HEALTHCARE CO INC?

The financial health rating of ACADIA HEALTHCARE CO INC (ACHC) is 2 / 10.


Is the dividend of ACADIA HEALTHCARE CO INC sustainable?

The dividend rating of ACADIA HEALTHCARE CO INC (ACHC) is 0 / 10 and the dividend payout ratio is 0%.